Cargando…

Unlocking NuriPep 1653 From Common Pea Protein: A Potent Antimicrobial Peptide to Tackle a Pan-Drug Resistant Acinetobacter baumannii

While the antibiotic era has come and gone, antimicrobial peptides (AMPs) hold promise as novel therapies to treat multidrug resistant (MDR) pathogens in an age where the threat of multidrug resistance escalates worldwide. Here, we report the bactericidal properties of NuriPep 1653, a novel 22 mer a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohan, Niamh Maire, Zorgani, Amine, Jalowicki, Gael, Kerr, Alish, Khaldi, Nora, Martins, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759681/ https://www.ncbi.nlm.nih.gov/pubmed/31620099 http://dx.doi.org/10.3389/fmicb.2019.02086

Ejemplares similares

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

Preservatives from food—For food: Pea protein hydrolysate as a novel bio‐preservative against Escherichia coli O157:H7 on a lettuce leaf
por: Mohan, Niamh M., et al.
Publicado: (2021)

An Artificial Intelligence Characterised Functional Ingredient, Derived from Rice, Inhibits TNF-α and Significantly Improves Physical Strength in an Inflammaging Population
por: Kennedy, Kathy, et al.
Publicado: (2020)

P1653: INFLAMMATION MEDIATED THROMBUS FORMATION IN LYMPHOMAS
por: Antic, Darko, et al.
Publicado: (2023)

MD1653 - Part 1: Characterisation of BLM Response at Collimators
por: Azzopardi, Gabriella, et al.
Publicado: (2018)

Nicholas Culpeper, Gent: Student in Physick and Astrologie 1616-1653-4
por: Chance, Burton
Publicado: (1931)

Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It
por: Ma, Chaoying, et al.
Publicado: (2021)

Bacteriophages as therapeutic & disinfectant agents to tackle multidrug-resistant Acinetobacter baumannii
por: Rathor, Nisha, et al.
Publicado: (2023)

Clinical characteristics of 1653 injured motorcyclists and factors that predict mortality from motorcycle crashes in Malaysia
por: Tan Chor Lip, Henry, et al.
Publicado: (2019)

1653. Transcriptional Variation of Adhesion and Biofilm Genes in CTX-M-15-Expressing Klebsiella pneumoniae
por: Maclean, Alyssa K W, et al.
Publicado: (2022)

Pep for PEP-II
Publicado: (1995)

Nonsynonymous C1653T Mutation of Hepatitis B Virus X Gene Enhances Malignancy of Hepatocellular Carcinoma Cells
por: Zhang, Cuifang, et al.
Publicado: (2022)

1653 Results of a Treatment Protocol Encouraging First-Line Use of Fidaxomicin for Select Patients with Clostridium difficile Infection (CDI)
por: Navalkele, Bhagyashri, et al.
Publicado: (2014)

1653. Estimation of country-specific tuberculosis antibiograms using a wide and deep neural net on a large genomic dataset
por: Dixit, Avika, et al.
Publicado: (2020)

P1653: CLINICAL EFFICACY AND SAFETY OF SWITCHING ELTROMBOPAG AND RH-TPO IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA DURING THE COVID-19 PANDEMIC
por: Cai, X., et al.
Publicado: (2022)

Complete genome analysis of clinical Shigella strains reveals plasmid pSS1653 with resistance determinants: a triumph of hybrid approach
por: Muthuirulandi Sethuvel, Dhiviya Prabaa, et al.
Publicado: (2019)

A Systematic Study of the Stability, Safety, and Efficacy of the de novo Designed Antimicrobial Peptide PepD2 and Its Modified Derivatives Against Acinetobacter baumannii
por: Chen, Sung-Pang, et al.
Publicado: (2021)

Unlocking the Potential of Molecularly Imprinted Polydopamine in Sensing Applications
por: Lamaoui, Abderrahman, et al.
Publicado: (2023)

Beams with PEP
Publicado: (1980)

PEP talk
Publicado: (1980)

PEP Workshop
Publicado: (1987)

Corrigendum: A Systematic Study of the Stability, Safety, and Efficacy of the de novo Designed Antimicrobial Peptide PepD2 and Its Modified Derivatives Against Acinetobacter baumannii
por: Chen, Sung-Pang, et al.
Publicado: (2022)

EMS Mutagenesis in the Pea Aphid Acyrthosiphon pisum
por: Tagu, Denis, et al.
Publicado: (2014)

PEP Summer Study
Publicado: (1973)

PEP, and more besides...
Publicado: (1980)

Stanford: Lots of PEP
Publicado: (1978)

Feedback experiment at PEP
por: Donald, M, et al.
Publicado: (1986)

The PEP-II design
por: Sullivan, M K
Publicado: (1995)

PEP design handbook
por: Stanford Linear Accelerator Center. Stanford
Publicado: (1977)

PEP proposals, 1-
por: Stanford Linear Accelerator Center. Stanford
Publicado: (1976)

PEP Summer Study
por: University of California. Berkeley. Radiation Laboratory
Publicado: (1974)

PEP Summer Study
por: Stanford Linear Accelerator Center. Stanford, et al.
Publicado: (1973)

PEP Summer Study
por: University of California. Berkeley. Radiation Laboratory
Publicado: (1975)

The PETRA and PEP programmes
por: Wolf, G, et al.
Publicado: (1979)

Performance evaluation of PEP
por: Zisman, M S
Publicado: (1987)

Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients
por: Tatsukawa, Masashi, et al.
Publicado: (2011)

1653. Cost effectiveness of Levofloxacin Vs Amoxicillin/Clavulanate And Ciprofloxacin In The Outpatient Management Of Low-Risk Febrile Neutropaenia In Children With Cancer: A Randomised Control Study.
por: Khedr, Reham, et al.
Publicado: (2023)

Unlocking the potential of molecular-driven stratification for osteosarcoma treatment and prognosis
por: Moquin-Beaudry, Gaël, et al.
Publicado: (2023)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_big7ihaq2u2n6kn7d2dui86k6b